ARS Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $6.94M | Buy |
|
|||||
|
2022
Q2 | $687K | Sell |
|
|||||
|
2022
Q1 | $51.4M | Sell |
|
|||||
|
2021
Q4 | $63.9M | Sell |
|
|||||
|
2021
Q3 | $64.8M | Sell |
|
|||||
|
2021
Q2 | $54.2M | Sell |
|
|||||
|
2021
Q1 | $38.4M | Buy |
|
|||||
|
2020
Q4 | $47.9M | Sell |
|
|||||
|
2020
Q3 | $36.4M | Sell |
|
|||||
|
2020
Q2 | $44.2M | Buy |
|
|||||
|
2020
Q1 | $20.5M | Buy |
|
|||||
|
2019
Q4 | $31.9M | Buy |
|
|||||
|
2019
Q3 | $23.8M | Buy |
|
|||||
|
2019
Q2 | $23.8M | Buy |
|
|||||
|
2019
Q1 | $23.9M | Buy |
|
|||||
|
2018
Q4 | $14.9M | Sell |
|
|||||
|
2018
Q3 | $15.6M | Buy |
|
|||||
|
2018
Q2 | $15.4M | Buy |
|
|||||
|
2018
Q1 | $6.7M | Buy |
|
|||||
|
2017
Q4 | $2.87M | Buy |
|